Tapia C - Search Results

1

Two mitosis-specific antibodies, MPM-2 and phospho-histone H3 (Ser28), allow rapid and precise determination of mitotic activity.

Tapia C, Kutzner H, Mentzel T, Savic S, Baumhoer D, Glatz K. Tapia C, et al. Am J Surg Pathol. 2006 Jan;30(1):83-9. doi: 10.1097/01.pas.0000183572.94140.43. Am J Surg Pathol. 2006. PMID: 16330946

2

Close association between HER-2 amplification and overexpression in human tumors of non-breast origin.

Tapia C, Glatz K, Novotny H, Lugli A, Horcic M, Seemayer CA, Tornillo L, Terracciano L, Spichtin H, Mirlacher M, Simon R, Sauter G. Tapia C, et al. Mod Pathol. 2007 Feb;20(2):192-8. doi: 10.1038/modpathol.3800729. Mod Pathol. 2007. PMID: 17361205 Free article.

3

Anatomic site-specific patterns of gene copy number gains in skin, mucosal, and uveal melanomas detected by fluorescence in situ hybridization.

Glatz-Krieger K, Pache M, Tapia C, Fuchs A, Savic S, Glatz D, Mihatsch M, Meyer P. Glatz-Krieger K, et al. Among authors: tapia c. Virchows Arch. 2006 Sep;449(3):328-33. doi: 10.1007/s00428-006-0167-8. Epub 2006 Mar 8. Virchows Arch. 2006. PMID: 16523260

4

HER2 gene status in primary breast cancers and matched distant metastases.

Tapia C, Savic S, Wagner U, Schönegg R, Novotny H, Grilli B, Herzog M, Barascud AD, Zlobec I, Cathomas G, Terracciano L, Feichter G, Bubendorf L. Tapia C, et al. Breast Cancer Res. 2007;9(3):R31. doi: 10.1186/bcr1676. Breast Cancer Res. 2007. PMID: 17511881 Free PMC article.

5

Evaluation of chromosomal aberrations in patients with benign conditions and reactive changes in urinary cytology.

Tapia C, Glatz K, Obermann EC, Grilli B, Barascud A, Herzog M, Schönegg R, Savic S, Bubendorf L. Tapia C, et al. Cancer Cytopathol. 2011 Dec 25;119(6):404-10. doi: 10.1002/cncy.20171. Epub 2011 Jul 5. Cancer Cytopathol. 2011. PMID: 21732550 Free article.

6

Comprehensive epidermal growth factor receptor gene analysis from cytological specimens of non-small-cell lung cancers.

Savic S, Tapia C, Grilli B, Rufle A, Bihl MP, de Vito Barascud A, Herzog M, Terracciano L, Baty F, Bubendorf L. Savic S, et al. Among authors: tapia c. Br J Cancer. 2008 Jan 15;98(1):154-60. doi: 10.1038/sj.bjc.6604142. Epub 2007 Dec 18. Br J Cancer. 2008. PMID: 18087280 Free PMC article.

7

Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer.

Cihoric N, Savic S, Schneider S, Ackermann I, Bichsel-Naef M, Schmid RA, Lardinois D, Gugger M, Bubendorf L, Zlobec I, Tapia C. Cihoric N, et al. Among authors: tapia c. Br J Cancer. 2014 Jun 10;110(12):2914-22. doi: 10.1038/bjc.2014.229. Epub 2014 May 22. Br J Cancer. 2014. PMID: 24853178 Free PMC article.

8

[EGFR mutation analysis in non-small-cell lung cancer : Experience from routine diagnostics].

Tapia C, Savic S, Bihl M, Rufle A, Zlobec I, Terracciano L, Bubendorf L. Tapia C, et al. Pathologe. 2009 Sep;30(5):384-92. doi: 10.1007/s00292-009-1141-4. Pathologe. 2009. PMID: 19357847 German.

9

Ki67 labeling index in core needle biopsies independently predicts tumor-specific survival in prostate cancer.

Bubendorf L, Tapia C, Gasser TC, Casella R, Grunder B, Moch H, Mihatsch MJ, Sauter G. Bubendorf L, et al. Among authors: tapia c. Hum Pathol. 1998 Sep;29(9):949-54. doi: 10.1016/s0046-8177(98)90199-x. Hum Pathol. 1998. PMID: 9744310

10

Deletion of the inhibitor of growth 4 (ING4) tumor suppressor gene is prevalent in human epidermal growth factor 2 (HER2)-positive breast cancer.

Tapia C, Zlobec I, Schneider S, Kilic E, Güth U, Bubendorf L, Kim S. Tapia C, et al. Hum Pathol. 2011 Jul;42(7):983-90. doi: 10.1016/j.humpath.2010.10.012. Epub 2011 Feb 11. Hum Pathol. 2011. PMID: 21315418 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

249 results

Search Page

Filters